Monitoring and Management of Patients on Therapy for Chronic Hepatitis B
This answer is incorrect. If a patient stops therapy at the first instance of an undetectable HBV DNA, it is quite likely that the HBV DNA will rebound, possibly causing a flare of hepatitis. For HBeAg-positive patients, antiviral therapy should be continued for at least 6 months after the HBV DNA is undetectable and HBeAg seroconversion has occurred.
Choose another answer: